Navidea biopharmaceuticals reminds investors of today's deadline to be a shareholder of record for the previously announced rights offering

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today issued a reminder to shareholders that the record date of its proposed rights offering is wednesday, august 3, 2022 (“record date”). to be a shareholder of record on the record date, ownership of navidea stock must occur by market close on monday, august 1, 2022 to account for s
NAVB Ratings Summary
NAVB Quant Ranking